List of Tables - Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market Expected to Grow at 8.1% by 2032

Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type (Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety (Cabozantinib), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Torisel (Temsirolimus), Sutent (Sunitinib), Votrient (Pazopanib)) - Growth, Future Prospects, And Competitive Analysis, 2024 -2032

13 Sep 2017 Format

TABLE 1 Global Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 2 North America Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 3 U.S. Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 4 Canada Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 5 Rest of North America Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 6 UK and European Union Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 7 UK Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 8 Germany Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 9 Spain Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 10 Italy Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 11 France Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 12 Rest of Europe Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 13 Asia Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 14 China Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 15 Japan Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 16 India Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 17 Australia Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 18 South Korea Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 19 Latin America Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 20 Brazil Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 21 Mexico Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 22 Rest of Latin America Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 23 Middle East and Africa Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 24 GCC Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 25 Africa Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)
TABLE 26 Rest of Middle East and Africa Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type, 2022-2032, USD (Million)